3 Cash-Producing Stocks We Think Twice About

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

Cash flow is valuable, but it’s not everything - StockStory helps you identify the companies that truly put it to work. That said, here are three cash-producing companies to steer clear of and a few better alternatives.

Hershey (HSY)

Trailing 12-Month Free Cash Flow Margin: 15.6%

Best known for its milk chocolate bar and Hershey's Kisses, Hershey (NYSE:HSY) is an iconic company known for its chocolate products.

Why Does HSY Worry Us?

1. Declining unit sales over the past two years suggest it might have to lower prices to stimulate growth
2. Expenses have increased as a percentage of revenue over the last year as its operating margin fell by 13.5 percentage points
3. Incremental sales over the last three years were much less profitable as its earnings per share fell by 9.5% annually while its revenue grew

Hershey is trading at $222.78 per share, or 26.7x forward P/E. Dive into our free research report to see why there are better opportunities than HSY.

Textron (TXT)

Trailing 12-Month Free Cash Flow Margin: 6.3%

Listed on the NYSE in 1947, Textron (NYSE:TXT) provides products and services in the aerospace, defense, industrial, and finance sectors.

Why Is TXT Not Exciting?

1. Large revenue base makes it harder to increase sales quickly, and its annual revenue growth of 4% over the last two years was below our standards for the industrials sector
2. Earnings per share lagged its peers over the last two years as they only grew by 4.5% annually
3. Free cash flow margin dropped by 3.4 percentage points over the last five years, implying the company became more capital intensive as competition picked up

At $92.87 per share, Textron trades at 14.7x forward P/E. Read our free research report to see why you should think twice about including TXT in your portfolio.

Progyny (PGNY)

Trailing 12-Month Free Cash Flow Margin: 14.9%

Pioneering a data-driven approach to family building that has achieved an industry-leading patient satisfaction score of +80, Progyny (NASDAQ:PGNY) provides comprehensive fertility and family building benefits solutions to employers, helping employees access quality fertility treatments and support services.

Why Are We Hesitant About PGNY?

1. Smaller revenue base of $1.29 billion means it hasn’t achieved the economies of scale that some industry juggernauts enjoy
2. Waning returns on capital imply its previous profit engines are losing steam

Progyny’s stock price of $18.19 implies a valuation ratio of 9.7x forward P/E. Check out our free in-depth research report to learn more about why PGNY doesn’t pass our bar.

High-Quality Stocks for All Market Conditions

ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren't just high-quality businesses. Something is happening with them right now. Elite fundamentals meeting near-term momentum — both boxes checked at the same time.

Find out which stocks our AI platform is flagging this week. See this week's Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.